翻訳と辞書 Words near each other ・ Paramylon ・ Paramylostoma ・ Paramyopsyche ・ Paramyotonia congenita ・ Paramyromeus loriai ・ Paramys ・ Paramysis ・ Paramysis baeri ・ Paramysis bakuensis ・ Paramount Animation ・ Paramount Arts Center ・ Paramount Bay at Edgewater Square ・ Paramount BioCapital ・ Paramount Cabinaire ・ Paramount Canadians Party ・ Paramount Capital ・ Paramount Cars ・ Paramount Channel (international) ・ Paramount chief ・ Paramount Chief Mpezeni ・ Paramount Chief Tuli Le’iato ・ Paramount chieftain ・ Paramount College of Natural Medicine ・ Paramount Comedy ・ Paramount Comedy Spain ・ Paramount Comics ・ Paramount Communications, Inc. v. QVC Network, Inc. ・ Paramount Country Club ・ Paramount Cricket Promotion Association Stadium ・ Paramount Crossroads Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Paramount Capital ： ウィキペディア英語版 Paramount Capital Paramount Capital is a global privately held pharmaceutical development and healthcare investment firm categorized under Financial Advisory Services. It is located in New York City.〔(Paramount Capital Inc on Manta )〕 The company is a conglomerate of firms including: Paramount BioSciences, Paramount BioCapital, Paramount Acquisition Company, Paramount Corporate Development, and Paramount BioCapital Asset Management. All of these companies represent separate entities, but interact to aid each other. For more than 19 years, the Paramount Capital group of companies supports the development of novel drugs and therapies, maintaining a solid commitment to cutting-edge therapies and medications with high potential. ==Background== Paramount Capital, Inc., was founded by Lindsay A. Rosenwald, M.D., in 1991. More than forty start-up companies, including Bradley Pharmaceuticals, Inc., Cougar Biotechnology, Cypress Bioscience, Inc., Genta, Inc, Innovive Pharmaceuticals, Novadel Pharma, Ziopharm Oncology, Tikvah Therapeutics, Inc.,〔 〕 VioQuest Pharmaceuticals, Bionovo Inc., and many others have been created over the past 19 years. Since its establishment, Paramount Capital and its divisions have been involved in the clinical development of more than 50 drug candidates, among which some have reached the market (including Arsenic Trioxide, leukemia drug that progressed from Investigational New Drug to New Drug Application in 30 months, which is considered to be one of the fastest regulatory approvals in U.S. Food and Drug Administration (FDA) history; milnacipran for fibromyalgia syndrome licensed from Pierre Fabre Medicament; Sulodexide (KRX-101) for diabetic nephropathy licensed into Keryx Biopharmaceuticals, Inc.; CH-1504 (MobileTrex) for rheumatoid arthritis licensed from University of South Alabama College Of Medicine by Chelsea Therapeutics. More than 30 compounds are still undergoing clinical development today. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Paramount Capital」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.